Clinical trials – Page 4
-
NewsInsider trading scandal topples head of Taiwan’s top research body
President of umbrella organisation overseeing 24 research institutions caught up in investigation into offloading of biotech shares prior to poor results
-
BusinessClinical trial death highlights hazards
Pain drug trial has left one dead and five hospitalised in France, with little indication as to the cause of the problems
-
Business
EU regulator calls for generic drug suspensions
The EMA wants hundreds of formulations off the market after identifying systematic fraud in a major Indian contract clinical research organisation
-
News
Tufts’ $2.6bn drug development figure questioned
Details sought about how university determined cost of bringing a drug to market jumped 145% since 2003
-
NewsEbola vaccine passes first safety hurdle
Researchers hope to begin larger trials of its effectiveness in west Africa soon
-
NewsUS agency fast-tracks Ebola vaccine development
Health and Human Services invests almost $6 million to ready an Ebola vaccine candidate for clinical trials, meanwhile GSK says its vaccine is progressing at an ‘unprecedented rate’
-
Business
EMA finalises trial transparency rules
Researcher access reinstated, but company redaction rights may cause issues
-
FeatureTransparency measures forced on pharma
Previous misdemeanours are compelling the pharmaceutical industry to be more open with financial information and clinical data, writes Nuala Moran
-
News
NIH wants scientists to consider sex in research
Preclinical and clinical research is overreliant on male test subjects which can cloud future work in humans
-
Business
Review says cheaper drug is safe for eye disease
Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar
-
Business
Servier to appear in adverts over lack of transparency
Adverts in the medical press will name French pharma firm for failing to comply with disclosure rules
-
NewsDoctors turn to experimental Ebola treatments
Drugs and vaccines untested in humans are being trialled on Ebola patients
-
BusinessEMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
Business
Biotech bounced back in 2013, says report
R&D investment increasing, but industry needs to use its cash more wisely
-
Business
UK to fast-track access to critical medicines
Patients could receive medicines before formal approval in exchange for monitoring data
-
BusinessRoche disputes unethical East German trial claims
Internal investigation concludes that 1980s trials were legally run and patients gave proper consent
-
BusinessJ&J puts trial data in independent hands
Yale University’s YODA seeks to help pharma avoid the dark side by acting as gatekeeper for patient records
-
Business
Novartis in the spotlight in mis-selling investigations
Crackdown on pharma marketing continues with US and Japanese cases
-
News
Rough patch for India’s clinical trial industry
Bad publicity has added to the woes of an industry worried by regulatory uncertainty
-
News
Supreme court ruling brings clinical trials to a halt in India
Pressure from campaign group precipitates action that puts 162 drug trials on ice